XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

Note 19. Income Taxes

The components of loss before income taxes are as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Domestic

 

$

(15,598

)

 

$

(16,006

)

Foreign

 

 

 

 

 

(126

)

Loss before income taxes

 

$

(15,598

)

 

$

(16,132

)

 

The total income tax expense for the years ended December 31, 2022 and 2021 was $14,000 and $2,000, respectively, and is comprised of current state taxes and foreign taxes withheld by governmental agencies outside of the United States, as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

(13

)

 

 

(2

)

Foreign

 

 

(1

)

 

 

 

Total current tax (expense)

 

 

(14

)

 

 

(2

)

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

Total deferred tax (expense)

 

 

 

 

 

 

Total tax (expense)

 

$

(14

)

 

$

(2

)

The Company operates in only one federal jurisdiction, the United States. The following is a reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Expected income tax provision at the federal statutory rate

 

 

21.0

%

 

 

21.0

%

State taxes, net of federal benefits

 

 

16.0

%

 

 

(20.1

)%

Impact of Section 382 Study

 

 

 

 

 

(10.4

)%

Change in valuation allowance

 

 

(40.9

)%

 

 

(0.4

)%

Transaction costs

 

 

 

 

 

(1.0

)%

Derivative liability

 

 

4.1

%

 

 

11.7

%

Contingent Consideration Release

 

 

0.1

%

 

 

 

Non-controlling interest

 

 

(0.3

)%

 

 

(1.9

)%

Gain on debt extinguishment

 

 

 

 

 

1.5

%

Other

 

 

(0.1

)%

 

 

(0.4

)%

Income tax provision

 

 

(0.1

)%

 

 

 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, net operating loss carryforwards (“NOLs”) and other tax credits. Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

 

 

 

As of December 31,

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

19,654

 

 

$

14,586

 

Unearned revenue

 

 

 

 

 

1

 

Stock-based compensation

 

 

4,541

 

 

 

3,677

 

Accrued payroll and benefits

 

 

296

 

 

 

3

 

Research and development credits

 

 

16

 

 

 

16

 

Fixed asset basis difference

 

 

54

 

 

 

73

 

Inventory reserve

 

 

445

 

 

 

422

 

Charitable contributions

 

 

2

 

 

 

2

 

Income from partnerships

 

 

97

 

 

 

163

 

Lease liability

 

 

531

 

 

 

752

 

Contingent consideration

 

 

 

 

 

456

 

Allowance for bad debt

 

 

65

 

 

 

27

 

Amortized intangibles

 

 

819

 

 

 

660

 

Goodwill

 

 

393

 

 

 

366

 

Section 174 Capitalization

 

 

340

 

 

 

 

Total deferred tax assets

 

 

27,253

 

 

 

21,204

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

 

(486

)

 

 

(699

)

Amortizable intangibles

 

 

 

 

 

 

Income from partnerships

 

 

 

 

 

 

Other

 

 

 

 

 

 

Total deferred tax liabilities

 

 

(486

)

 

 

(699

)

Less valuation allowance

 

 

(26,767

)

 

 

(20,505

)

Net deferred tax assets

 

$

 

 

$

 

Realization of the deferred tax assets is dependent upon future taxable income, if any, the amount and timing of which are uncertain. Accordingly, the net deferred tax assets have been offset by a valuation allowance. The net valuation allowance increased by $6.3 million during the year ended December 31, 2022 and decreased by $6,000 during the year ended December 31, 2021.

At December 31, 2022, the Company had federal and state NOLs aggregating approximately $81.1 million and $47.5 million, respectively. At December 31, 2022, the utilization of a portion of the federal NOLs is subject to an annual limitation under Section 382 of the Internal Revenue Code (IRC). Of the $222.3 million of federal NOLs available, approximately $141.2 million are expected to expire unutilized due to ownership changes as defined in IRC Section 382. If not utilized, the federal and state NOLs will begin to expire in 2023 and 2024, respectively. IRC Section 382 may also limit NOLs generated in future years.

The Company evaluates deferred tax assets, including the benefit from NOLs, to determine if a valuation allowance is required. Such evaluation is based on consideration of all available evidence using a “more likely than not” standard with significant weight being given to evidence that can be objectively verified. This assessment considers, among other matters, the nature, frequency, and severity of current and cumulative losses; forecasts of future profitability; the length of statutory carryforward periods; the Company’s experience with operating losses; and tax-planning alternatives. The significant piece of objective negative evidence evaluated was the cumulative loss incurred through the year ended December 31, 2022. Given this evidence and the expectation to incur operating losses in the foreseeable future, a full valuation allowance has been recorded against the net deferred tax asset. The Company will continue to maintain a full valuation allowance against the entire amount of its net deferred tax asset,

until such time as the Company has determined that the weight of the objectively verifiable positive evidence exceeds that of the negative evidence and it is likely that the Company will be able to utilize all of its net deferred tax asset relating to its federal and state NOL carryforwards. Although the Company has established a full valuation allowance on its net deferred tax asset, for Federal tax losses before 2018 and for all state tax losses, it has not forfeited the right to carryforward tax losses up to 20 years and apply such tax losses against taxable income in such years, thereby reducing its future tax obligations. Federal tax losses generated in 2018 and later do not expire. The Company is subject to taxation in the United States and various state jurisdictions. As of December 31, 2022, the Company’s tax years for 2003 through 2022 are generally subject to examination by the tax authorities. The years are open back to 2003 to the extent the NOLs being carried forward were generated then.

As of December 31, 2022, the Company had the following unrecognized tax benefits (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Unrecognized tax benefit beginning balance

 

$

17

 

 

$

17

 

Increases for tax positions taken in prior years

 

 

 

 

 

 

Decreases for tax positions taken in prior years

 

 

(1

)

 

 

 

Increases for tax positions taken in current years

 

 

 

 

 

 

Settlements

 

 

 

 

 

 

Unrecognized tax benefit ending balance

 

$

16

 

 

$

17

 

In February 2023, the Company received notification from the Internal Revenue Service that our Archipelago joint venture was selected for audit for the 2021 tax year. The Opening Conference is scheduled for April 24, 2023, and Management has not yet received the IRS agent’s Initial Document Request.

The Company is currently not under audit for state purposes. The Company does not anticipate its total unrecognized tax benefits as of December 31, 2022 will significantly change due to settlement of examination or the expiration of statute of limitations during the next 12 months. The Company is currently unaware of any uncertain tax positions that could result in significant additional payments, accruals or other material deviation in this estimate over the next 12 months.